Literature DB >> 25308351

Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study.

Wolfgang Strube1, Tilmann Bunse1, Michael A Nitsche2, Thomas Wobrock3, Richard Aborowa4, Kristina Misewitsch4, Maximiliane Herrmann4, Peter Falkai1, Alkomiet Hasan1.   

Abstract

Impaired neuroplastic responses following noninvasive brain stimulation have been reported repeatedly in schizophrenia patients. These findings have been associated with deficits in GABAergic, glutamatergic, and cholinergic neurotransmission. Although various neurophysiological studies have indicated a relationship between nicotine and neuroplasticity in healthy individuals, the present study is the first investigation into the impact of nicotine on LTD-like plasticity in patients with schizophrenia. Cortical excitability and cortical plasticity were explored in 30 schizophrenia patients (17 smoker, 13 nonsmoker) and 45 healthy controls (13 smoker, 32 nonsmoker) by using single-pulse transcranial magnetic stimulation (TMS) before and following cathodal transcranial direct current stimulation (tDCS) applied to the left primary motor cortex. Our analysis revealed abolished LTD-like plasticity in nonsmoking schizophrenia patients. However, these plasticity deficits were not present in smoking schizophrenia patients. In healthy controls, significant MEP reductions following cathodal tDCS were observed in nonsmoking individuals, but only trend-level reductions in smokers. In smoking schizophrenia patients, the severity of negative symptoms correlated positively with reduced neuroplasticity, whereas nonsmoking patients displayed the opposite effect. Taken together, the data of our study support the notion of an association between chronic smoking and the restitution of impaired LTD-like plasticity in schizophrenia patients. Although replication and further research are needed to better understand this relationship, our findings indicate that nicotine intake might stabilize the impaired inhibition-facilitation balance in the schizophrenic brain through a complex interaction between cortical plasticity, and GABAergic and cholinergic neurotransmission, and might explain the reduced prevalence of negative symptoms in this population.

Entities:  

Mesh:

Year:  2014        PMID: 25308351      PMCID: PMC4330512          DOI: 10.1038/npp.2014.275

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  50 in total

1.  Impaired long-term depression in schizophrenia: a cathodal tDCS pilot study.

Authors:  Alkomiet Hasan; Michael A Nitsche; Maximiliane Herrmann; Thomas Schneider-Axmann; Louise Marshall; Oliver Gruber; Peter Falkai; Thomas Wobrock
Journal:  Brain Stimul       Date:  2011-09-05       Impact factor: 8.955

2.  Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Authors:  Kristi A Sacco; Angelo Termine; Aisha Seyal; Melissa M Dudas; Jennifer C Vessicchio; Suchitra Krishnan-Sarin; Peter I Jatlow; Bruce E Wexler; Tony P George
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 3.  Smoking, nicotine and neuropsychiatric disorders.

Authors:  Peter Dome; Judit Lazary; Miklos Peter Kalapos; Zoltan Rihmer
Journal:  Neurosci Biobehav Rev       Date:  2009-08-07       Impact factor: 8.989

4.  Nicotinergic impact on focal and non-focal neuroplasticity induced by non-invasive brain stimulation in non-smoking humans.

Authors:  Nivethida Thirugnanasambandam; Jessica Grundey; Kim Adam; Anne Drees; Angela C Skwirba; Nicolas Lang; Walter Paulus; Michael A Nitsche
Journal:  Neuropsychopharmacology       Date:  2010-12-15       Impact factor: 7.853

5.  Nicotine stimulates dendritic arborization in motor cortex and improves concurrent motor skill but impairs subsequent motor learning.

Authors:  Claudia L R Gonzalez; Omar A Gharbawie; Ian Q Whishaw; Bryan Kolb
Journal:  Synapse       Date:  2005-03-01       Impact factor: 2.562

6.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

Review 7.  Motor cortical excitability assessed by transcranial magnetic stimulation in psychiatric disorders: a systematic review.

Authors:  Tilmann Bunse; Thomas Wobrock; Wolfgang Strube; Frank Padberg; Ullrich Palm; Peter Falkai; Alkomiet Hasan
Journal:  Brain Stimul       Date:  2013-12-14       Impact factor: 8.955

Review 8.  Computational models of schizophrenia and dopamine modulation in the prefrontal cortex.

Authors:  Edmund T Rolls; Marco Loh; Gustavo Deco; Georg Winterer
Journal:  Nat Rev Neurosci       Date:  2008-09       Impact factor: 34.870

9.  Nicotine and synaptic plasticity in prefrontal cortex.

Authors:  Daniel S McGehee
Journal:  Sci STKE       Date:  2007-08-14

10.  Dysfunctional neural plasticity in patients with schizophrenia.

Authors:  Zafiris J Daskalakis; Bruce K Christensen; Paul B Fitzgerald; Robert Chen
Journal:  Arch Gen Psychiatry       Date:  2008-04
View more
  10 in total

1.  Motor cortical plasticity in schizophrenia: A meta-analysis of Transcranial Magnetic Stimulation - Electromyography studies.

Authors:  Urvakhsh Meherwan Mehta; Milind Vijay Thanki; Jaya Padmanabhan; Alvaro Pascual-Leone; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2018-11-06       Impact factor: 4.939

Review 2.  Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development.

Authors:  Colleen A Hanlon; Logan T Dowdle; J Scott Henderson
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 3.  Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.

Authors:  Daniel J Foster; P Jeffrey Conn
Journal:  Neuron       Date:  2017-05-03       Impact factor: 17.173

4.  Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model.

Authors:  A Ghoshal; J M Rook; J W Dickerson; G N Roop; R D Morrison; N Jalan-Sakrikar; A Lamsal; M J Noetzel; M S Poslusney; M R Wood; B J Melancon; S R Stauffer; Z Xiang; J S Daniels; C M Niswender; C K Jones; C W Lindsley; P J Conn
Journal:  Neuropsychopharmacology       Date:  2015-06-25       Impact factor: 7.853

Review 5.  The effects of medication use in transcranial direct current stimulation: A brief review.

Authors:  Molly E McLaren; Nicole R Nissim; Adam J Woods
Journal:  Brain Stimul       Date:  2017-10-12       Impact factor: 8.955

6.  Altered Motor-Striatal Plasticity and Cortical Functioning in Patients with Schizophrenia.

Authors:  Dongsheng Zhou; Feng Pang; Shiyan Liu; Ying Shen; Lingjiang Liu; Zezhong Fang; Chuang Wang; Zhenyu Hu; Ti-Fei Yuan
Journal:  Neurosci Bull       Date:  2016-11-12       Impact factor: 5.203

Review 7.  [Non-invasive brain stimulation for treatment of schizophrenic psychoses].

Authors:  A Hasan; T Wobrock; U Palm; W Strube; F Padberg; P Falkai; A Fallgatter; C Plewnia
Journal:  Nervenarzt       Date:  2015-12       Impact factor: 1.214

8.  Elevated mirror neuron system activity in bipolar mania: Evidence from a transcranial magnetic stimulation study.

Authors:  Rakshathi Basavaraju; Urvakhsh M Mehta; Alvaro Pascual-Leone; Jagadisha Thirthalli
Journal:  Bipolar Disord       Date:  2018-12-12       Impact factor: 6.744

9.  The two-way relationship between nicotine and cortical activity: a systematic review of neurobiological and treatment aspects.

Authors:  Carlota de Miquel; Benjamin Pross; Irina Papazova; Duygu Güler; Alkomiet Hasan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-27       Impact factor: 5.270

10.  Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline.

Authors:  G Batsikadze; W Paulus; A Hasan; J Grundey; M-F Kuo; M A Nitsche
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.